van Bokhorst Kirsten L, Galac Sara, Kooistra Hans S, de Grauw Janny C, Teske Erik, Grinwis Guy C M, van Nimwegen Sebastiaan A
Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
IVC Evidensia, Vleuten, Netherlands.
Front Vet Sci. 2023 Aug 16;10:1156801. doi: 10.3389/fvets.2023.1156801. eCollection 2023.
Adrenalectomy is the treatment of choice in case of functional adrenal tumors and malignant adrenal incidentalomas. Laparoscopic adrenalectomy (LA) in dogs has gained popularity in recent years, however, clinical studies on large patient populations are scarce. This retrospective study describes perioperative and recurrence data, survival, and prognostic factors in 70 dogs that underwent LA or open adrenalectomy (OA) in our hospital between 2008 and 2022. Diagnosis was based on history, clinical signs, endocrine function tests and advanced diagnostic imaging. Laparoscopic adrenalectomy was performed in 42 dogs ( = 27 naturally occurring hypercortisolism, = 4 pheochromocytoma, = 1 pheochromocytoma with concurrent hypercortisolism, = 10 incidentaloma) and OA in 28 dogs ( = 22 hypercortisolism, = 3 pheochromocytoma, = 3 incidentaloma). Bilateral adrenalectomy was performed in 8/70 dogs. Surgical duration of LA and OA did not differ significantly in unilateral and bilateral procedures ( = 0.108 and = 0.101, respectively). Systemic hypertension occurred in 7/41 and 1/28 dogs during LA and OA, respectively ( = 0.130). Hypotension occurred in 2/41 and 4/28 dogs during LA and OA, respectively ( = 0.214). A total of 40/42 dogs in the LA group and 27/28 in the OA group survived to discharge ( = 0.810). Mean hospital stay was significantly shorter ( = 0.006) after LA (1.5 days, range 1-3) than after OA (2.2 days, range 1-4). No significant differences were demonstrated between LA and OA groups in recurrence of adrenal-dependent endocrine disease ( = 0.332), disease-free period ( = 0.733) and survival time ( = 0.353). The disease-specific 1-, 2- and 3-year survival rates were 95, 89, and 89% after LA and 92, 88, and 81% after OA. Tumor size was significantly associated with the occurrence of a recurrence. In addition, tumor size had a negative effect on the disease-free period and survival time. This study shows a favorable outcome of both LA and OA in dogs. Based on low perioperative complication rate, short hospitalization time and long-term outcomes comparable to OA in selected cases, the less invasive laparoscopic approach is considered the preferred technique.
对于功能性肾上腺肿瘤和恶性肾上腺偶发瘤,肾上腺切除术是首选治疗方法。近年来,犬腹腔镜肾上腺切除术(LA)越来越受欢迎,然而,针对大量患者群体的临床研究却很稀少。这项回顾性研究描述了2008年至2022年间在我院接受LA或开放性肾上腺切除术(OA)的70只犬的围手术期和复发数据、生存率及预后因素。诊断基于病史、临床症状、内分泌功能测试和先进的诊断成像。42只犬接受了腹腔镜肾上腺切除术(其中27只患有自然发生的皮质醇增多症,4只患有嗜铬细胞瘤,1只患有并发皮质醇增多症的嗜铬细胞瘤,10只患有偶发瘤),28只犬接受了开放性肾上腺切除术(22只患有皮质醇增多症,3只患有嗜铬细胞瘤,3只患有偶发瘤)。70只犬中有8只接受了双侧肾上腺切除术。在单侧和双侧手术中,LA和OA的手术时间无显著差异(分别为P = 0.108和P = 0.101)。LA和OA过程中,分别有7/41只和1/28只犬发生全身性高血压(P = 0.130)。LA和OA过程中,分别有2/41只和4/28只犬发生低血压(P = 0.214)。LA组42只犬中有40只、OA组28只犬中有27只存活至出院(P = 0.810)。LA术后平均住院时间(1.5天,范围1 - 3天)显著短于OA术后(2.2天,范围1 - 4天)(P = 0.006)。LA组和OA组在肾上腺依赖性内分泌疾病复发率(P = 0.332)、无病生存期(P = 0.733)和生存时间(P = 0.353)方面无显著差异。LA术后疾病特异性1年、2年和3年生存率分别为95%、89%和89%,OA术后分别为92%、88%和81%。肿瘤大小与复发的发生显著相关。此外,肿瘤大小对无病生存期和生存时间有负面影响。本研究表明LA和OA在犬中均有良好的预后。基于围手术期并发症发生率低、住院时间短以及在某些情况下与OA相当的长期预后,创伤较小的腹腔镜手术方法被认为是首选技术。